Patent Description:
Currently, siloxane - (meth)acrylate compounds can be synthesized via a direct platinum catalyzed hydrosilylation reaction of a (meth)acryloxy-functional alkenyl compound and an organohydrogensiloxane oligomer, as exemplified below in Equation <NUM> by the reaction of allyl methacrylate <NUM> with <NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>-heptamethyltrisiloxane <NUM>. This reaction is for example disclosed in document <CIT>. However, this direct reaction suffers from the drawbacks of poor yield, on the order of <NUM>% to <NUM>% of the desired product (exemplified by MD'M-ALMA <NUM> in Equation <NUM>) with significant amounts of side products, including an oxy-silylester and an alkylene hydrosilylated product (exemplified in Equation <NUM> by oxy-silyl ester <NUM> and propylene hydrosilylated adduct <NUM>, respectively). The oxy-silylester byproduct has a similar boiling point to the MD'M-ALMA, making distillation difficult, time consuming, and expensive.

A method for preparing an ester - functional siloxane comprises combining starting materials comprising (A) an alkenyl ether and (B) an organohydrogensiloxane oligomer in the presence of (C) a hydrosilylation reaction catalyst and (D) a promoter.

More specifically, the method for preparing the ester - functional siloxane comprises:.

Step (<NUM>) of the method described above may comprise mixing and heating the starting materials. The starting materials may be combined in any order. Alternatively, (C) the platinum hydrosilylation reaction catalyst and (D) the promoter may be combined with one of (A) the alkenyl ether and (B) the organohydrogensiloxane oligomer to form a reaction mixture, and thereafter the other of (A) the alkenyl ether and (B) the organohydrogensiloxane oligomer may be metered into the reaction mixture, either continuously or intermittently. For example, starting materials comprising (A) the alkenyl ether, (C) the platinum hydrosilylation reaction catalyst, and (D) the promoter may be combined to form the reaction mixture, and (B) the organohydrogensiloxane oligomer may be metered into the reaction mixture.

Alternatively, the method may optionally further comprise, before step (<NUM>) combining (C) the platinum hydrosilylation reaction catalyst and (D) the promoter before combination with (A) the alkenyl ether and (B) the organohydrogensiloxane oligomer. Starting material (E), a solvent, may be used in step (<NUM>), or before step (<NUM>), e.g., to facilitate mixing of the starting materials, such as to facilitate mixing of (C) the platinum hydrosilylation reaction catalyst and (D) the promoter. Mixing may be performed at ambient or elevated temperature, e.g., RT to less than boiling point of the solvent selected, such as RT to <NUM>.

Without wishing to be bound by theory, it is thought that combining (C) the platinum hydrosilylation reaction catalyst; and (D) the promoter, optionally in the presence of (E) the solvent, before combination with other starting materials may cause a platinum - ligand complex to form (where the promoter is the ligand), and that this complex may then act as the catalyst in step (<NUM>). The starting materials introduced above will now be described in detail, below.

Starting material (A) is an alkenyl ether of formula (A1):
<CHM>
where R<NUM> is a monovalent hydrocarbon group of <NUM> to <NUM> carbon atoms, and R<NUM> is selected from the group consisting of hydrogen and an alkyl group of <NUM> to <NUM> carbon atoms. Alternatively, each R<NUM> may be H.

Alternatively, R<NUM> may be selected from the group consisting of alkyl groups of <NUM> to <NUM> carbon atoms and alkenyl groups of <NUM> to <NUM> carbon atoms. The alkyl group for R<NUM> and/or R<NUM> may be methyl, ethyl, propyl (including n-propyl and isopropyl), butyl (including n-butyl, t-butyl, sec-butyl, and isobutyl), pentyl (including n-pentyl, cyclopentyl, and branched isomers with <NUM> carbon atoms), hexyl (including n-hexyl, cyclohexyl, and branched isomers with <NUM> carbon atoms). Alternatively, the alkyl group may be methyl or ethyl; alternatively methyl. The alkenyl group for R<NUM> may be vinyl, allyl, hexenyl, or a branched alkenyl group. For example, the alkenyl group may have formula
<CHM>
and (A) may be allyl methacrylate, which is commercially available from various sources such as Sigma Aldrich, Inc. Louis, Missouri, USA. Alternatively, the alkenyl group for R<NUM> may have formula
<CHM>
and (A) may be allyl acrylate, which is commercially available from various sources such as Sigma Aldrich, Inc. Alternatively, when R<NUM> is methyl, (A) may be allyl acetate, which is commercially available from various sources such as Sigma Aldrich, Inc.

Alternatively, starting material (A) may be a (meth)acrylate-functional alkenyl compound of formula (A2):
<CHM>
where R<NUM> is selected from the group consisting of H, alkyl, and aryl; R<NUM> is selected from the group consisting of H, alkyl, and aryl; and R<NUM> is selected from the group consisting of H, alkyl, and aryl. Suitable alkyl groups for R<NUM>, R<NUM> and R<NUM> may have <NUM> to <NUM> carbon atoms, alternatively <NUM> to <NUM> carbon atoms. The alkyl groups are exemplified by methyl, ethyl, propyl (including n-propyl and/or isopropyl), butyl (including n-butyl, tert-butyl, sec-butyl, and/or isobutyl); pentyl, hexyl, heptyl, octyl, decyl, dodecyl (and branched isomers having <NUM> to <NUM> carbon atoms), and the alkyl groups are further exemplified by cycloalkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. Alternatively, the alkyl group may be selected from the group consisting of methyl, ethyl, propyl and butyl; alternatively methyl, ethyl, and propyl; alternatively methyl and ethyl. Alternatively, the alkyl group may be methyl. Suitable aryl groups may be monocyclic or polycyclic and may have pendant hydrocarbyl groups. For example, the aryl groups include phenyl, tolyl, xylyl, and naphthyl and further include aralkyl groups such as benzyl, <NUM>-phenylethyl and <NUM>-phenylethyl. Alternatively, the aryl group may be monocyclic, such as phenyl, tolyl, or benzyl; alternatively the aryl group may be phenyl. Alternatively, R<NUM>, R<NUM> and R<NUM> may each be selected from the group consisting of H and methyl. Alternatively, R<NUM> may be H. Alternatively, R<NUM> may be H. Alternatively, R<NUM> may be methyl. Examples of suitable commercially available compounds for starting material (A) include allyl (meth)acrylate. Suitable (meth)acrylate-functional alkenyl compounds are commercially available, e.g., from Sigma Aldrich, Inc. Louis, Missouri, USA.

Starting material (B) used in step (<NUM>) of the method described herein is an organohydrogensiloxane oligomer. The organohydrogensiloxane oligomer has at least one silicon bonded hydrogen atom per molecule, alternatively exactly one silicon bonded hydrogen atom per molecule. The organohydrogensiloxane oligomer may have unit formula (B1): (R<NUM><NUM>SiO<NUM>/<NUM>)a(R<NUM><NUM>HSiO<NUM>/<NUM>)b(HR<NUM>SiO<NUM>/<NUM>)c(R<NUM><NUM>SiO<NUM>/<NUM>)d, where each R<NUM> is as described above, subscripts a, b, c, and d each represent average numbers of a unit in the unit formula and have values such that <NUM> ≤ a ≤ <NUM>; <NUM> ≤ b ≤ <NUM>; <NUM> ≤ c ≤ <NUM>, <NUM> ≤ d ≤ <NUM>, a quantity (a + b) = <NUM>, a quantity (b + c) ≥ <NUM>, and a quantity (a + b + c + d) is <NUM> to <NUM>. Alternatively, <NUM> ≥ (a + b + c + d) ≥ <NUM>, alternatively <NUM> ≥ (a + b + c + d) ≥ <NUM>, alternatively <NUM> ≥ (a + b + c + d) ≥ <NUM>, and alternatively (a + b + c + d) = <NUM>.

Alternatively, starting material (B) may be have formula
<CHM>
, or
<CHM>
where R<NUM> is as described above, and R<NUM> is selected from the group consisting of H and R<NUM>, with the proviso that at least one R<NUM> per molecule is H. Alternatively, one R<NUM> per molecule is H and one R<NUM> per molecule is R<NUM>.

Alternatively, starting material (B) may be an organohydrogensiloxane oligomer of
<CHM>
or
<CHM>
where R<NUM> is as described above.

Suitable organohydrogensiloxane oligomers for starting material (B) are known in the art and are commercially available. For example, suitable organohydrogensiloxane oligomers for starting material (B) may be <NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>-heptamethyltrisiloxane, or <NUM>,<NUM>,<NUM>,<NUM>-tetramethyldisiloxane, which are available from, e.g., Sigma-Aldrich, Inc. Louis, Missouri, USA. Alternatively, starting material (B) may be <NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>-heptamethyltrisiloxane.

Starting material (B) may be one organohydrogensiloxane oligomer, or a combination of two or more oligomers that differ from one another in at least one respect, e.g., selection of R<NUM>, position of the silicon bonded hydrogen, and/or DP. However, (A) the alkenyl ether and (B) the organohydrogensiloxane oligomer are in amounts such that a molar ratio of the amount of (B) the organohydrogensiloxane oligomer: (A) the alkenyl ether (B):(A) is <NUM>:<NUM> to <NUM>: <NUM>, alternatively <NUM>:<NUM> to <NUM>:<NUM>, used in step (<NUM>).

Starting material (C) is a hydrosilylation reaction catalyst. The hydrosilylation reaction catalyst will promote a reaction between the alkenyl groups in starting material (A) the alkenyl ether and the silicon bonded hydrogen atoms in starting material (B) the organohydrogensiloxane. Said catalyst comprises platinum. The hydrosilylation reaction catalyst may be (C1) platinum metal, described above; (C2) a compound of platinum metal, for example, chloroplatinic acid (Speier's Catalyst), chloroplatinic acid hexahydrate, platinum dichloride, (C3) a complex of the compound with an alkenyl functional organopolysiloxane, or (C4) a platinum compound microencapsulated in a matrix or coreshell type structure. Complexes of platinum with low molecular weight organopolysiloxanes include a vinyldimethylsiloxane complex with platinum, such as <NUM>,<NUM>-diethenyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethyldisiloxane complexes with platinum (Karstedt's Catalyst) and Pt(<NUM>) complex in tetramethyltetravinylcyclotetrasiloxane (Ashby's Catalyst). Alternatively, the hydrosilylation reaction catalyst may be (C5) a compound or complex, as described above, microencapsulated in a resin matrix. Specific examples of suitable platinum-containing catalysts for use herein include chloroplatinic acid, either in hexahydrate form or anhydrous form, or a platinum-containing catalyst which is obtained by a method comprising reacting chloroplatinic acid with an aliphatically unsaturated organosilicon compound such as divinyltetramethyldisiloxane, or alkene-platinum-silyl complexes as described in <CIT> to Roy. These alkene-platinum-silyl complexes may be prepared, for example by mixing <NUM> mole (COD)PtCl<NUM> with <NUM> mole COD and <NUM> moles HMeSiCl<NUM>, where COD represents cyclooctadienyl. Other exemplary hydrosilylation reaction catalysts are described in <CIT>; <CIT>; <CIT>; <CIT>, <CIT>; <CIT>; <CIT>; <CIT>; <CIT>; <CIT>, <CIT>, <CIT>; <CIT>, <CIT>; and <CIT> Suitable hydrosilylation reaction catalysts for starting material (C) are commercially available, for example, SYL-OFF™ <NUM> Catalyst and SYL-OFF™ <NUM> are available from DSC.

Starting material (C) may be one platinum hydrosilylation reaction catalyst or a combination of two or more of the platinum hydrosilylation reaction catalysts described above. The amount of (C) the platinum hydrosilylation reaction catalyst used in the method will depend on various factors including the selection of starting materials (A), (B), and (D), however, the amount of catalyst is sufficient to catalyze hydrosilylation reaction of SiH and alkenyl groups, alternatively the amount of catalyst is sufficient to provide at least <NUM> ppm, alternatively at least <NUM> ppm, alternatively at least <NUM> ppm, alternatively at least <NUM> ppm, and alternatively at least <NUM> ppm, by mass of the platinum group metal based on combined amounts of starting materials (A), (B), (C), and (D) used in step (<NUM>) of the method described herein. At the same time, the amount of catalyst is sufficient to provide up to <NUM>,<NUM> ppm, alternatively up to <NUM> ppm, alternatively up to <NUM> ppm, and alternatively up to <NUM> ppm by mass of the platinum group metal, on the same basis.

Starting material (D) used in the method described herein is (D) a promoter, which has general formula:
<CHM>
where each group of formula
<CHM>
is independently selected from the group consisting of cyclohexyl and phenyl; each R<NUM> is an independently selected an alkyl group of <NUM> to <NUM> carbon atoms; and each subscript x is independently <NUM>, <NUM>, or <NUM>. Each R<NUM>, when present, is covalently bonded to a carbon atom in a cyclohexyl or phenyl ring. Suitable alkyl groups for R<NUM> include methyl, ethyl, propyl and butyl; alternatively methyl and ethyl; and alternatively methyl. Each subscript x may be <NUM>, <NUM>, or <NUM>; alternatively <NUM> or <NUM>; and alternatively each x = <NUM>. Each instance of subscript x may be the same or different. Alternatively, (D) the promoter may be selected from the group consisting of: (D1) bis(diphenylphosphino)methane, (D2) bis(dicyclohexylphosphino)methane, and (D3) a combination of both (D1) and (D2). Alternatively, the promoter may be (D1) bis(diphenylphosphino)methane. Alternatively, the promoter may be (D2) bis(dicyclohexylphosphino)methane. Each of these compounds is commercially available from various sources, e.g., from Sigma Aldrich, Inc. , TCI America, or Alfa Aesar.

The amount of promoter used in the method is sufficient to provide both a yield ratio of the ester - functional siloxane: the oxy - silyl ester side product of ≥ <NUM>:<NUM> and a conversion of starting materials (A) and (B) ≥ <NUM>%. Alternatively, the amount of promoter may be sufficient to provide both a yield ≥ <NUM>:<NUM> and a conversion of starting materials (A) and (B) ≥ <NUM>%. Alternatively, the amount of promoter may be sufficient to provide both a yield ratio ≥ <NUM>:<NUM> and a conversion of starting materials (A) and (B) ≥ <NUM>%. Alternatively, the amount of promoter may be > <NUM> mol to < <NUM> mol, per <NUM> mol of platinum from starting material (C). Alternatively, the amount of promoter may be at least <NUM> mol, alternatively > <NUM> mol, while at the same time the amount of promoter may be up to <NUM>, alternatively < <NUM> mol, per <NUM> mol of platinum from starting material (C).

Starting material (E) is a solvent, which may be used to facilitate mixing of one or more of the starting materials. For example, (C) the platinum hydrosilylation reaction catalyst may be delivered in a solvent and/or (C) the platinum hydrosilylation reaction catalyst and (D) the promoter may be combined in a solvent before step (<NUM>). Suitable solvents include a polydialkylsiloxane, a monohydric alcohol, an aromatic hydrocarbon, an aliphatic hydrocarbons, and a combination of two or more thereof. Polyalkylsiloxanes with suitable vapor pressures may be used as the solvent, and these include hexamethyldisiloxane, octamethyltrisiloxane, hexamethylcyclotrisiloxane and other low molecular weight polyalkylsiloxanes, such as <NUM> to <NUM> cSt DOWSIL™ <NUM> Fluids and DOWSIL™ OS FLUIDS, which are commercially available from DSC. The monohydric alcohol may have <NUM> to <NUM> carbon atoms, such as methanol, ethanol, isopropanol, n-propanol, n-butanol, t-butanol, isobutanol and/or sec-butanol. The aromatic hydrocarbon may have <NUM> to <NUM> carbon atoms, such as benzene, toluene, ethyl benzene, or xylene. The aliphatic hydrocarbon may have <NUM> to <NUM> carbon atoms such as heptane, hexane, cyclohexane, or octane. The monohydric alcohols and hydrocarbon solvents are commercially available from various sources, such as Sigma Aldrich, Inc. Louis, Missouri, USA. Starting material (E) may be one solvent or a combination of two or more of the solvents described above.

The amount of solvent will depend on various factors including the type of solvent selected and the amount and type of other starting materials selected for use in the method. However, the amount of solvent may be <NUM>% to <NUM>%, based on combined weights of all starting materials used in step (<NUM>).

The method may optionally further comprise adding (F) a (meth)acrylate polymerization inhibitor (inhibitor) before and/or during step (<NUM>).

Starting material (F) is a (meth)acrylate polymerization inhibitor (inhibitor) that may optionally be used in the method. The inhibitor is not limited, and may comprise, alternatively may be, a radical scavenger, an antioxidant, a light stabilizer, a UV-absorber, or a combination thereof. Such inhibitors are known in the art and include a chemical compound or moiety capable of interacting with a free radical to render the free radical inactive, e.g., via elimination the free radical through the formation of a covalent bond therewith. The inhibitor may alternatively be a polymerization retardant, i.e., a compound that reduces the rate of initiation and/or propagation of a radical polymerization. For example, the inhibitor may comprise, alternatively may be, oxygen gas. In general, the inhibitor is utilized to prevent and/or suppress the formation of side products that may be formed via radical polymerization of a moiety on starting material (A).

The inhibitor (F) may comprise a phenolic compound, a quinone or hydroquinone compound, an N-oxyl compound, a phenothiazine compound, a hindered amine compound, or a combination thereof. Examples of phenolic compounds include phenol, alkylphenols, aminophenols (e.g. p-aminophenol), nitrosophenols, and alkoxyphenols. Specific examples of such phenol compounds include o-, m- and p-cresol(methylphenol), <NUM>-tert-butyl-<NUM>-methylphenol, <NUM>-tert-butyl-<NUM>,<NUM>-dimethylphenol, <NUM>,<NUM>-di-tert-butyl-<NUM>-methylphenol, <NUM>-tert-butylphenol, <NUM>-tert-butylphenol, <NUM>,<NUM>-di-tert-butylphenol, <NUM>-methyl-<NUM>-tert-butylphenol, <NUM>-tert-butyl-<NUM>,<NUM>-dimethylphenol or <NUM>,<NUM>'-methylenebis(<NUM>-tert-butyl-<NUM>-methylphenol), <NUM>,<NUM>'-oxybiphenyl, <NUM>,<NUM>-methylenedioxydiphenol (sesamol), <NUM>,<NUM>-dimethylphenol, pyrocatechol (<NUM>,<NUM>-dihydroxybenzene), <NUM>-(<NUM>'-methylcyclohex-<NUM>'-yl)-<NUM>,<NUM>-dimethylphenol, <NUM>- or <NUM>-(<NUM>'-phenyleth-<NUM>'-yl)phenol, <NUM>-tert-butyl-<NUM>-methylphenol, <NUM>,<NUM>,<NUM>-tris-tert-butylphenol, <NUM>,<NUM>-di-tert-butylphenol, nonylphenol, octylphenol, <NUM>,<NUM>-dimethylphenol, bisphenol A, bisphenol B, bisphenol C, bisphenol F, bisphenol S, <NUM>,<NUM>',<NUM>,<NUM>'-tetrabromobisphenol A, <NUM>,<NUM>-di-tert-butyl-p-cresol,, methyl <NUM>,<NUM>-di-tert-butyl-<NUM>-hydroxybenzoate, <NUM>-tert-butylpyrocatechol, <NUM>-hydroxybenzyl alcohol, <NUM>-methoxy-<NUM>-methylphenol, <NUM>,<NUM>,<NUM>-trimethylphenol, <NUM>,<NUM>,<NUM>-trimethylphenol, <NUM>,<NUM>,<NUM>-trimethylphenol, <NUM>-isopropylphenol, <NUM>-isopropylphenol, <NUM>-isopropyl-m-cresol, n-octadecyl β-(<NUM>,<NUM>-di-tert-butyl-<NUM>-hydroxyphenyl)propionate, <NUM>,<NUM>,<NUM>-tris(<NUM>-methyl-<NUM>-hydroxy-<NUM>-tert-butylphenyl)butane, <NUM>,<NUM>,<NUM>-trimethyl-<NUM>,<NUM>,<NUM>-tris-(<NUM>,<NUM>-di-tert-butyl-<NUM>-hydroxybenzyl)benzene, <NUM>,<NUM>,<NUM>,-tris(<NUM>,<NUM>-di-tert-butyl-<NUM>-hydroxybenzyl)isocyanurate, <NUM>,<NUM>,<NUM>-tris(<NUM>,<NUM>-di-tert-butyl-<NUM>-hydroxyphenyl)propionyloxyethyl isocyanurate, <NUM>,<NUM>,<NUM>-tris(<NUM>,<NUM>-dimethyl-<NUM>-hydroxy-<NUM>-tert-butylbenzyl)isocyanurate or pentaerythrityl tetrakis[p-(<NUM>,<NUM>-di-tert-butyl-<NUM>-hydroxyphenyl)propionate], <NUM>,<NUM>-di-tert-butyl-<NUM>-dimethylaminomethylphenol, <NUM>-sec-butyl-<NUM>,<NUM>-dinitrophenol, octadecyl <NUM>-(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionate, hexadecyl <NUM>-(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionate, octyl <NUM>-(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionate, <NUM>-thia-<NUM>,<NUM>-pentanediol bis[(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionate], <NUM>,<NUM>-dioxa-<NUM>,<NUM>-undecanediol bis[(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionate], <NUM>,<NUM>-dioxa-<NUM>,<NUM>-undecanediol bis[(<NUM>'-tert-butyl-<NUM>'-hydroxy-<NUM>'-methylphenyl)propionate], <NUM>,<NUM>-nonanediol bis[(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionate], <NUM>,<NUM>-heptanediaminebis[<NUM>-(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionamide], <NUM>,<NUM>-methanediaminebis[<NUM>-(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionamide], <NUM>-(<NUM>',<NUM>'-di-tert-butyl-<NUM>'-hydroxyphenyl)propionic acid hydrazide, <NUM>-(<NUM>',<NUM>'-dimethyl-<NUM>'-hydroxyphenyl)propionic acid hydrazide, bis(<NUM>-tert-butyl-<NUM>-ethyl-<NUM>-hydroxyphen-<NUM>-yl)methane, bis(<NUM>,<NUM>-di-tert-butyl-<NUM>-hydroxyphen-<NUM>-yl)methane, bis[<NUM>-(<NUM>'-methylcyclohex-<NUM>'-yl)-<NUM>-methyl-<NUM>-hydroxyphen-<NUM>-yl]methane, bis(<NUM>-tert-butyl-<NUM>-hydroxy-<NUM>-methylphen-<NUM>-yl)methane, <NUM>,<NUM>-bis(<NUM>-tert-butyl-<NUM>-hydroxy-<NUM>-methylphen-<NUM>-yl)ethane, bis(<NUM>-tert-butyl-<NUM>-hydroxy-<NUM>-methylphen-<NUM>-yl) sulfide, bis(<NUM>-tert-butyl-<NUM>-hydroxy-<NUM>-methylphen-<NUM>-yl) sulfide, <NUM>,<NUM>-bis(<NUM>,<NUM>-dimethyl-<NUM>-hydroxyphen-<NUM>-yl)-<NUM>-methylpropane, <NUM>,<NUM>-bis(<NUM>-tert-butyl-<NUM>-methyl-<NUM>-hydroxyphen-<NUM>-yl)butane, <NUM>,<NUM>,<NUM>-tris-[<NUM>'-(3Δ,<NUM>"-di-tert-butyl-<NUM>"-hydroxyphen-<NUM>"-yl)meth-<NUM>'-yl]-<NUM>,<NUM>,<NUM>-trimethylbenzene, <NUM>,<NUM>,<NUM>-tris(<NUM>'-tert-butyl-<NUM>'-hydroxy-<NUM>'-methylphen-<NUM>'-yl)butane and tert-butylcatechol, p-nitrosophenol, p-nitroso-o-cresol, methoxyphenol (guaiacol, pyrocatechol monomethyl ether), <NUM>-ethoxyphenol, <NUM>-isopropoxyphenol, <NUM>-methoxyphenol (hydroquinone monomethyl ether), mono- or di-tert-butyl-<NUM>-methoxyphenol, <NUM>,<NUM>-di-tert-butyl-<NUM>-hydroxyanisole, <NUM>-hydroxy-<NUM>-methoxybenzyl alcohol, <NUM>,<NUM>-dimethoxy-<NUM>-hydroxybenzyl alcohol, <NUM>-hydroxy-<NUM>-methoxybenzaldehyde, <NUM>-hydroxy-<NUM>-ethoxybenzaldehyde, <NUM>-hydroxy-<NUM>-methoxybenzaldehyde, <NUM>-(<NUM>-hydroxy-<NUM>-methoxyphenyl)ethanone, eugenol, dihydroeugenol, isoeugenol, tocopherols, such as α-, β-, γ-, δ- and ε-tocopherol, tocol, α-tocopherolhydroquinone, <NUM>,<NUM>-dihydro-<NUM>,<NUM>-dimethyl-<NUM>-hydroxybenzofuran (<NUM>,<NUM>-dimethyl-<NUM>-hydroxycoumaran), and combinations thereof.

Suitable quinones and hydroquinones include hydroquinone, hydroquinone monomethyl ether(<NUM>-methoxyphenol), methylhydroquinone, <NUM>,<NUM>-di-tert-butylhydroquinone, <NUM>-methyl-p-hydroquinone, <NUM>,<NUM>-dimethylhydroquinone, trimethylhydroquinone, <NUM>-methylpyrocatechol, tert-butylhydroquinone, <NUM>-methylpyrocatechol, benzoquinone, <NUM>-methyl-p-hydroquinone, <NUM>,<NUM>-dimethylhydroquinone, tert-butylhydroquinone, <NUM>-ethoxyphenol, <NUM>-butoxyphenol, hydroquinone monobenzyl ether, p-phenoxyphenol, <NUM>-methylhydroquinone, tetramethyl-p-benzoquinone, diethyl-<NUM>,<NUM>-cyclohexanedione <NUM>,<NUM>-dicarboxylate, phenyl-p-benzoquinone, <NUM>,<NUM>-dimethyl-<NUM>-benzyl-p-benzoquinone, <NUM>-isopropyl-<NUM>-methyl-p-benzoquinone (thymoquinone), <NUM>,<NUM>-diisopropyl-p-benzoquinone, <NUM>,<NUM>-dimethyl-<NUM>-hydroxy-p-benzoquinone, <NUM>,<NUM>-dihydroxy-p-benzoquinone, embelin, tetrahydroxy-p-benzoquinone, <NUM>,<NUM>-dimethoxy-<NUM>,<NUM>-benzoquinone, <NUM>-amino-<NUM>-methyl-p-benzoquinone, <NUM>,<NUM>-bisphenylamino-<NUM>,<NUM>-benzoquinone, <NUM>,<NUM>-dihydroxy-<NUM>,<NUM>-naphthoquinone, <NUM>-anilino-<NUM>,<NUM>-naphthoquinone, anthraquinone, N,N-dimethylindoaniline, N,N-diphenyl-p-benzoquinonediimine, <NUM>,<NUM>-benzoquinone dioxime, coerulignone, <NUM>,<NUM>'-di-tert-butyl-<NUM>,<NUM>'-dimethyldiphenoquinone, p-rosolic acid (aurin), <NUM>,<NUM>-di-tert-butyl-<NUM>-benzylidenebenzoquinone, <NUM>,<NUM>-di-tert-amylhydroquinone, and combinations thereof.

Suitable N-oxyl compounds (i.e., nitroxyl or N-oxyl radicals) include compounds which have at least one N-O• group, such as <NUM>-hydroxy-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-N-oxyl, <NUM>-oxo-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-N-oxyl, <NUM>-methoxy-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-N-oxyl, <NUM>-acetoxy-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-N-oxyl, <NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-N-oxyl (TEMPO), <NUM>,<NUM>',<NUM>"-tris(<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-N-oxyl)phosphite, <NUM>-oxo-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpyrrolidin-N-oxyl, <NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethyl-<NUM>-methoxypiperidine, <NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethyl-<NUM>-trimethylsilyloxypiperidine, <NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl <NUM>-ethylhexanoate, bis(<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)oxyl sebacate, <NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl stearate, <NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl-benzoate, <NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl (<NUM>-tert-butyl)benzoate, bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin4-yl) succinate, bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl) adipate, bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)<NUM>,<NUM>-decanedioate, bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin4-yl)n-butylmalonate, bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl) phthalate, bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)isophthalate, bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin4-yl) terephthalate, bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl) hexahydroterephthalate, N,N'-bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)adipamide, N-(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)caprolactam, N-(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)dodecylsuccinimide, <NUM>,<NUM>,<NUM>-tris[N-butyl-N-(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl]triazine, N,N'-bis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)-N,N'-bisformyl-<NUM>,<NUM>-diaminohexane, <NUM>,<NUM>'-ethylenebis(<NUM>-oxyl-<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperazin-<NUM>-one), and combinations thereof.

Other compounds suitable for use in or as the inhibitor include phenothiazine (PTZ) and compounds with similar structures, such as phenoxazine, promazine, N,N'-dimethylphenazine, carbazole, N-ethylcarbazole, N-benzylphenothiazine, N-(<NUM>-phenylethyl)phenothiazine, N-Alkylated phenothiazine derivatives such as N-benzylphenothiazine and N-(<NUM>-phenylethyl)phenothiazine, and combinations thereof. The inhibitor may be one compound or a combination of two or more of different compounds, as described an exemplified above. Alternatively, the inhibitor may comprise (<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)oxyl (TEMPO), <NUM>-hydroxy (<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)oxyl (4HT), bis(<NUM>,<NUM>,<NUM>,<NUM>-tetramethylpiperidin-<NUM>-yl)oxyl sebacate (Bis-TEMPO), polymer-bound TEMPO, or a combination thereof.

The method may optionally further comprise one or more additional steps. For example, the method may further comprise (<NUM>) recovering the ester - functional siloxane from the reaction product prepared in step (<NUM>). Recovering may be performed by any convenient means, such as stripping and/or distillation, optionally with heating and/or reduced pressure. Without wishing to be bound by theory, it is thought that any unreacted starting materials may be recycled in a subsequent reaction. Alternatively, recovering may be performed to separate the ester - functional siloxane and the platinum hydrosilylation reaction catalyst (or complex of said catalyst with the promoter).

The ester - functional siloxane prepared by the method may have unit formula (G1): (R<NUM><NUM>SiO<NUM>/<NUM>)a(R<NUM><NUM>R<NUM>SiO<NUM>/<NUM>)b(R<NUM>R<NUM>SiO<NUM>/<NUM>)c(R<NUM><NUM>SiO<NUM>/<NUM>)d, where each R<NUM> and subscripts a, b, c, and d are as described above, and each R<NUM> is a group of formula
<CHM>
where R<NUM> and R<NUM> are as described above.

These examples are intended to illustrate the invention to one skilled in the art and are not to be interpreted as to limit the invention set forth in the claims.

In this Reference Example <NUM>, hydrosilylation reaction of allyl methacrylate and <NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>-heptamethyltrisiloxane (HMTS) using a platinum catalyst to form <NUM>-(<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>-heptamethyltrisiloxan-<NUM>-yl)propyl methacrylate (MD'M-ALMA) was studied (see Equation <NUM>, above). Samples were prepared as follows: In a N<NUM> filled glovebox, <NUM> (<NUM> mmol) of Karstedt catalyst (<NUM>% Pt by weight in xylene solution, commercially available from Millipore Sigma, CAS number <NUM>-<NUM>-<NUM>) was charged into a GC vial. When used, a promoter was added to the catalyst solution such that the (Pt: promoter) ratio was <NUM>:<NUM>. The resulting catalyst solution was left undisturbed for <NUM> prior to use. The proper volume of this catalyst solution (<NUM>µL, <NUM> ppm) was then added to <NUM> mmol of allyl methacrylate (shown in Equation <NUM> as substrate <NUM> ) (<NUM>) and <NUM> ppm TEMPO (used as inhibitor) in to a <NUM>-dram vial and heated to <NUM>. <NUM> mmol of HMTS (<NUM>) was slowly injected into the reaction vial. The reaction temperature was maintained at <NUM> and monitored by GC-FID/<NUM>H NMR. Once the GC-FID showed partial or complete consumption of substrate <NUM> (generally after <NUM> to <NUM>), the heating block was removed and the resulting product was further analyzed by NMR spectroscopy.

GC-FID conditions were as follows: GC-FID were run on an Agilent 7890A equipped with an Agilent DB-<NUM> capillary (<NUM> x <NUM> x <NUM>; Length, ID, Film). The method was holding at <NUM> for <NUM>, then ramping to <NUM> at <NUM> ° min-<NUM> and hold at <NUM> for <NUM>.

Example <NUM> in Table <NUM> shows that failure to include a promoter resulted in poor selectivity under the conditions tested. The yield ratio of desired product, MD'M-ALMA, produced relative to the oxy - silyl ester side product was only <NUM>:<NUM>. Furthermore, examples <NUM> and <NUM> showed that comparative phosphine compounds, such as those disclosed in <CIT>, also promoted poor selectivity under the conditions tested.

In contrast, examples <NUM> and <NUM> showed that dppm and dchpm all produced reaction products with both <NUM>) high selectivity to the desired product, MD'M-ALMA (e.g., with yield ratio ≥ <NUM>:<NUM>) and <NUM>) good conversion of the starting materials (e.g., ≥ <NUM>%).

In this Reference Example <NUM>, the reaction described in Reference Example <NUM> was run using different loadings of dppm and catalyst. The results are shown below in Table <NUM>.

The data in Table <NUM> showed that the amount of promoter can affect yield and selectivity.

In this Reference Example <NUM>, hydrosilylation reaction of allyl acetate (<NUM>) and HMTS using a platinum catalyst and dppm to form <NUM>-(<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>-heptamethyltrisiloxan-<NUM>-yl)propyl acetate (<NUM>) was studied.

Samples were prepared as follows: In a N<NUM> filled glovebox, <NUM> (<NUM> mmol) of Karstedt's catalyst (<NUM>% Pt by weight in Xylene solution, commercially available from Millipore Sigma, CAS number <NUM>-<NUM>-<NUM>) was charged into a GC vial. The proper amount of diphenylphosphinomethane promoter (<NUM>, <NUM> mmol) was added to the catalyst solution such that the (Pt: promoter) ratio was in the range of <NUM>:<NUM> to <NUM>: <NUM>. The catalyst solution was left undisturbed for <NUM> prior use. The proper volume of this catalyst solution (<NUM>µL, <NUM> ppm) was then added to <NUM> mmol of allyl acetate (substrate <NUM>) (<NUM>) and <NUM> ppm TEMPO (used as inhibitor) in a <NUM>-dram vial and heated to <NUM>. <NUM> mmol of HMTS (<NUM>) was slowly injected into the vial. The reaction temperature was maintained at <NUM> and monitored by GC-FID/<NUM>H NMR. Once the GC-FID showed partial or complete consumption of allyl acetate (substrate <NUM>) (generally needed <NUM>-<NUM>), the heating block was removed and the resulting product was further analyzed by NMR spectroscopy.

GC-FID conditions: GC-FID were run on an Agilent 7890A equipped with an Agilent DB-<NUM> capillary (<NUM> x <NUM> x <NUM>; Length, ID, Film). The method was holding at <NUM> for <NUM>, then ramping to <NUM> at <NUM> ° min-<NUM> and hold at <NUM> for <NUM>.

The results in Table <NUM> showed that use of the dppm promoter was effective to produce a product with good yield (≥ <NUM>%, higher than the control without promoter) and selectivity to <NUM>-(<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>,<NUM>-heptamethyltrisiloxan-<NUM>-yl)propyl acetate under the conditions tested.

A method for preparing an ester - functional siloxane has benefits over a previous method that does not include a promoter as described herein. The combination of benefits includes both <NUM>) high selectivity to the desired ester - functional siloxane (e.g., with a yield ratio of the ester - functional siloxane: oxy -silyl ester side product) of ≥ <NUM>:<NUM>) and <NUM>) good conversion of the starting materials (e.g., ≥ <NUM>%).

All amounts, ratios, and percentages are by weight unless otherwise indicated. The articles 'a', 'an', and 'the' each refer to one or more, unless otherwise indicated by the context of specification. The singular includes the plural unless otherwise indicated. The term "comprising" and derivatives thereof, such as "comprise" and "comprises" are used herein in their broadest sense to mean and encompass the notions of "including," "include," "consist(ing) essentially of," and "consist(ing) of. The use of "for example," "e.g.," "such as," and "including" to list illustrative examples does not limit to only the listed examples. Thus, "for example" or "such as" means "for example, but not limited to" or "such as, but not limited to" and encompasses other similar or equivalent examples.

It is to be understood that the appended claims are not limited to express any particular compounds, compositions, or methods described in the detailed description, which may vary between particular embodiments which fall within the scope of the appended claims. With respect to any Markush groups relied upon herein for describing particular features or aspects of various embodiments, different, special, and/or unexpected results may be obtained from each member of the respective Markush group independent from all other Markush members. Each member of a Markush group may be relied upon individually and or in combination and provides adequate support for specific embodiments within the scope of the appended claims.

Abbreviations used herein are defined in Table <NUM>.

Claim 1:
A method for preparing an ester - functional siloxane, wherein the method comprises: (<NUM>) combining starting materials comprising
(A) an alkenyl ether of formula
<CHM>
where R<NUM> is a monovalent hydrocarbon group of <NUM> to <NUM> carbon atoms, and R<NUM> is selected from the group consisting of hydrogen and an alkyl group of <NUM> to <NUM> carbon atoms;
(B) an organohydrogensiloxane oligomer of unit formula
(R<NUM><NUM>SiO<NUM>/<NUM>)a(R<NUM><NUM>HSiO<NUM>/<NUM>)b(HR<NUM>SiO<NUM>/<NUM>)c(R<NUM><NUM>SiO<NUM>/<NUM>)d, where each R<NUM> is an independently selected monovalent hydrocarbon group of <NUM> to <NUM> carbon atoms, subscripts a, b, c, and d each represent average numbers of a unit in the unit formula and have values such that <NUM> ≤ a ≤ <NUM>; <NUM> ≤ b ≤ <NUM>; <NUM> ≤ c ≤ <NUM>, <NUM> ≤ d ≤ <NUM>, a quantity (a + b) = <NUM>, a quantity (b + c) ≥ <NUM>, and a quantity (a + b + c + d) is <NUM> to <NUM>;
where (A) the alkenyl ether and (B) the organohydrogensiloxane oligomer are present in amounts such that a molar ratio of the amount of (B) the organohydrogensiloxane oligomer: (A) the alkenyl ether (B):(A) is <NUM>:<NUM> to <NUM>:<NUM>;
(C) a platinum hydrosilylation reaction catalyst; and
an amount sufficient to provide a both a yield ratio of the ester - functional siloxane : an oxy -silyl ester side product of ≥ <NUM>:<NUM> and a conversion of starting materials (A) and (B) ≥ <NUM>% of (D) a promoter of formula
<CHM>
where each group of formula
<CHM>
is independently selected from the group consisting of cyclohexyl and phenyl; each R<NUM> is an independently selected an alkyl group of <NUM> to <NUM> carbon atoms; and each subscript x is independently <NUM>, <NUM>, or <NUM>.